Table 2: Treatment results of childhood B-cell NHL in different working groups.
Study |
Country |
No patients |
Time period |
Protocol |
EFS |
OS |
Wessels et al. [7] |
S. Africa |
63 |
1983-2002 |
COMP, LMB-89,96 |
25-87% |
|
Reiter et al. [2] |
Germany |
111 |
1986-1990 |
BFM-86 |
|
81% |
Burkhardt et al. [8] |
International |
1004 |
1986-2002 |
BFM-86, 90, 95 |
87% |
|
Patte et al. [4] |
France |
420 |
1989-1996 |
LMB-89 |
92% |
|
Müller et al. [9] |
Hungary |
108 |
1990-2004 |
BFM-90, 95 |
81% |
83% |
Cairo et al. [10] |
USA |
46 |
1991-1995 |
Orange, CCG-5911 |
80% |
|
Kavan et al. [11] |
Czech Republic |
82 |
1991-1997 |
BFM-90 |
74% |
80% |
Pillon et al. [12] |
Italy |
105 |
1992-1997 |
AIEOP-LNH 92 |
87.5% |
|
Chantada et al. [13] |
Argentina |
57 |
1994-1999 |
BFM-90 |
79% |
81% |
Marky et al. [14] |
Nordic countries |
121 |
1995-2000 |
NOPHONHL-95 |
91% |
91% |
Celkan et al. [15] |
Turkey |
48 |
1995-2007 |
BFM-95 |
76.6% |
78.1% |
Patte et al. [4] |
France |
397 |
1996-2001 |
LMB-96 |
93.3% |
|
Dokmanovic et al. [16] |
Serbia |
57 |
1997-2011 |
BFM-95 |
84.1% |
93% |
Eldar et al. [17] |
Israel |
88 |
2000-2005 |
LMB-96 |
88.6% |
90.9% |
Tsurusawa et al. [18] |
Japan |
321 |
2001-2012 |
B-NHL03 |
87.4% |
92.7% |
Sun et al. [19] |
China |
138 |
1998-2011 |
Modified BFM-90 |
85.8% |
85.8% |
Nelson et al. [20] |
USA |
90 |
1996-2001 |
CCG-5961 |
|
89% |